Evidence map›Paper›PMID 38315122›Full record

ArticleMicrobiology spectrum2024

Hydroxyhexylitaconic acids as potent IMP-type metallo-β-lactamase inhibitors for controlling carbapenem resistance in

Jun-Ichi Wachino, Wanchun Jin, Chihiro Norizuki, Kouji Kimura, Motonori Tsuji, Hiromasa Kurosaki, Yoshichika Arakawa

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jun-Ichi WachinoDepartment of Medical Technology, Faculty of Medical Sciences, Shubun University, Ichinomiya, Aichi, Japan.ORCID 0000-0002-2619-8380
Wanchun JinCollege of Pharmacy, Kinjo Gakuin University, Nagoya, Aichi, Japan.
Chihiro NorizukiDepartment of Medical Technology, Faculty of Medical Sciences, Shubun University, Ichinomiya, Aichi, Japan.
Kouji KimuraDepartment of Bacteriology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.ORCID 0000-0002-3783-6333
Motonori TsujiInstitute of Molecular Function, Misato, Saitama, Japan.
Hiromasa KurosakiCollege of Pharmacy, Kinjo Gakuin University, Nagoya, Aichi, Japan.
Yoshichika ArakawaDepartment of Medical Technology, Faculty of Medical Sciences, Shubun University, Ichinomiya, Aichi, Japan.
Shubun University · JPKinjo Gakuin University · JPNagoya University · JP

Funding

Japan Agency for Medical Research and Development (AMED) JP17nk0101368MEXT | Japan Society for the Promotion of Science (JSPS) JP21H02967
6 · The paper itself

Abstract

Metallo-β-lactamases (MBLs) represent one of the main causes of carbapenem resistance in the order

Indexed as

beta-Lactamase InhibitorsBiological ProductsAnti-Bacterial Agentsbeta-LactamasesCarbapenemsEscherichia coliIonsMicrobial Sensitivity TestsZincAnti-Bacterial Agentsbeta-Lactamase Inhibitorsbeta-LactamasesBiological ProductsCarbapenemsIonsZincEnterobacteralesinhibitorsmetallo-β-lactamase

Identifiers

PMID38315122
PMCPMC10913484
OpenAlexW4391542293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.